Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

News

Sygnature is proud of its many achievements, research collaborations and awards and delighted to publish these achievements wherever possible. Below you can read and hear about exciting new developments within the organization.

Filter by:

News

Sygnature Discovery expands DMPK capabilities with acquisition of XenoGesis

READ ARTICLE

News

Sygnature and RenaSci strengthen drug abuse leadership with appointment of Dr Andy Mead

READ ARTICLE

News

Sygnature Discovery boosts senior management team with appointment of Dr Paul Overton

READ ARTICLE

Drug Discovery News

Sygnature assists New York Medical College in the fight against Covid-19

READ ARTICLE

News Therapeutic Areas

Sygnature expands capabilities with acquisition of Alderley Oncology

READ ARTICLE

Bioscience Drug Discovery News

Sygnature Discovery expands SPR capacity

READ ARTICLE

News

Sygnature Group adds pharmacology expertise to BD team with recruitment of Dr David Loczenski

READ ARTICLE

News

Sygnature provides equipment to Government’s COVID-19 testing efforts

READ ARTICLE

News

Key Appointments and Retirements at RenaSci

READ ARTICLE

News

COVID-19 – Update

READ ARTICLE

News

COVID-19 and business continuity

READ ARTICLE

News

Sygnature strengthens DMPK team

READ ARTICLE
MORE...

Upcoming Events

View All
09 Sep 2020

ReThinking Drug Discovery

webinar series

REGISTER HERE
06 Oct 2020

ELRIG – Drug…

Digital

VISIT WEBSITE
09 Sep 2020

ReThinking Drug Discovery

webinar series

REGISTER HERE